All news

Steven A. Cohen reports an Avalo Therapeutics (AVTX) stake but owns no shares directly.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen have reported a collective beneficial ownership of 1,625,019 Avalo Therapeutics, Inc. (AVTX) common shares, representing 3.0% of the class as of September 30, 2026. While they hold shared voting and dispositive power over these shares, none of the reporting persons directly own any Avalo shares.

Read original source

AVTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.